Ursodeoxycholate Alleviates Alcoholic Fatty Liver Damage in Rats

Abstract

The hydrophilic bile salt ursodeoxycholate (UDC) improves cholestasis in several liver diseases and is in vitro an efficient membrane stabilizer. However, its action on chronic ethanol-induced liver damage is not established. We thus sought to determine the effect of UDC on chronic ethanol-induced steatosis and on liver plasma membrane fluidity in rats. Male rats were pair-fed liquid diets containing 36% of calories as ethanol (alcohol diet) or an isocaloric maltose-dextrin mixture (control diet). Four groups of 10 animals received, respectively, during 30 days: the control diet, the control diet + UDC (90 mg/kg/day), the alcohol diet, and the alcohol diet + UDC. Bile was collected for assessment of bile flow, biliary lipids, and individual bile salts. Liver lipid contents and lipid peroxidation were determined. Plasma membrane fluidity was assessed by fluorescence polarization of various probes. Alcohol treatment caused a 4-fold increase in liver triacylglycerol and cholesterol ester levels. UDC supplementation significantly reduced these increases by 50% and 40%, respectively. UDC intake was associated with a marked decrease in alcohol-induced lipid peroxidation. Bile flow, bile salt, and phospholipid secretion were slightly increased by alcohol intake. The addition of UDC-enriched bile with tauroursodeoxycholate (38%) without significantly affecting the biliary parameters. Lastly, UDC treatment almost totally prevented the 20% increase in liver plasma membrane fluidity due to chronic alcohol intake. This study shows that UDC intake, concomitant with alcohol diet, exerts a clear-cut membrane protective effect that might alleviate ethanol-induced lipid disorders.

Zebrafish larva as a reliable model forin vivoassessment of membrane remodeling involvement in the hepatotoxicity of chemical agents

“…Based upon the fact that in rodents, ethanol-induced membrane remodeling and consequent liver injuries were studied after a long-term exposure to alcohol from 10 to 30 days (Oliva et al, 1998;Yin et al, 2001;Inokuchi et al, 2011;Roh et al, 2015), we decided to mimic this exposure time in zebrafish larvae using a 7-day treatment with ethanol. Concerning the comparison with an in vitro model, our previous results obtained in primary rat hepatocytes could not be used owing to the too short incubation time with ethanol (within a maximum of 5 h).…”

Metabolomic study of Chinese medicine Huang Qin decoction as an effective treatment for irinotecan-induced gastrointestinal toxicity

“…57 As bile acids modulate lipid, glucose and energy metabolism, disturbance of bile acid metabolism is a vital risk in several disease, including fatty liver diseases and GI cancer. [58][59][60][61][62] A recent study showed that intestinal peroxisome proliferator-activated receptor a (PPARa)-UDPglucuronosyltransferases (UGTs) signaling plays an important role in bile acid homostasis. 57 As the active metabolite of CPT-11, SN-38 is metabolized to inactive SN-38G via UGT.…”

Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption

“…Activation of intestinal FXR by bile acids leads to up‐regulation of fibroblast growth factor 15 (FGF15) (3, 4), and secreted FGF15 suppresses liver transcription of cholesterol 7α‐hydroxylase 1 (CYP7A1), the rate‐limiting enzyme for liver bile acid biosynthesis (5). Errors in bile acid metabolism are implicated in several human diseases, including both alcoholic (6) and nonalcoholic fatty liver diseases (7) and colon cancer (8). The gut microbiome may play a role in the development of a variety of diseases such as obesity, diabetes mellitus, fatty liver disease, and colon cancer (9).…”